The small Maf proteins (MafG, MafK, and MafF), which serve as heterodimeric partner molecules of CNC family proteins for binding in vitro to MARE sites, have been implicated in the regulation of both transcription and chromatin structure, but there is no current evidence that the proteins fulfill these functions in vivo. To elucidate possible contributions of the small Maf proteins to gene regulation, we have ablated the mafG and mafK genes in mice by replacing their entire coding sequences with the Escherichia coli lacZ gene. mafG homozygous mutant animals exhibit impaired platelet formation accompanied by megakaryocyte proliferation, as well as behavioral abnormalities, whereas mafK-null mutant mice are phenotypically normal. Characterization of the mafG and mafK embryonic expression patterns show that their developmental programs are distinct and intersecting, but not entirely overlapping. These results provide direct evidence that the small Maf transcription factors are vital participants in embryonic development and cellular differentiation.
The product of the maf proto-oncogene and its related family members (the Maf family proteins) share well conserved basic and leucine zipper (bZip) motifs that mediate DNA binding and dimer formation. Members of the Maf family are divided into two subfamilies: the large Maf proteins, c-Maf (Nishizawa et al. 1989) , MafB (Kataoka et al. 1994a) , and NRL (Swaroop et al. 1992 ), all of which contain a distinctive acidic domain that enables transcriptional activation, and the small Maf proteins, MafK (Fujiwara et al. 1993) , MafF (Fujiwara et al. 1993) and MafG (Kataoka et al. 1995) , which appear to consist of little more than the essential regions required for DNA binding and heptad repeat interactions.
Transcription factor NF-E2 is composed of two subunits, p45 and p18 (Andrews et al. 1993a,b; Igarashi et al. 1994) , where the p18 subunit was shown to be a small Maf protein (for reviews, see Blank and Andrews 1997; Motohashi et al. 1997) . Heterodimers of p45 and small Mafs can activate transcription from MAREs [Maf recognition elements, TGCTGAC(T/GT)CAGCA], whereas small Maf homodimers form active repressors acting on the same sites (Nagai et al. 1998 ). Adding to this regulatory complexity, p45 was subsequently identified as only one member of a larger group of proteins that now constitute the mammalian cap'n'collar (CNC; Mohler et al. 1991) protein family-these are called p45, Nrf1 (/LCRF1/TCF11), Nrf2 (/ECH), Bach1, and Bach2 (Chan et al. 1993; Caterina et al. 1994; Luna et al. 1994; Moi et al. 1994; Itoh et al. 1995; Oyake et al. 1996) . These five CNC family members display similar heterodimeric interactions, but also include unique differences in transactivation potential in association with the small Maf proteins Johnsen et al. 1996; Oyake et al. 1996) . As noted originally, the MARE also encompasses a consensus AP-1 binding site (Engel 1994) . It has been shown that the small Maf proteins can interact with c-Fos, whereas the large Mafs can heterodimerize with c-Fos and/or c-Jun (Kataoka et al. 1994b (Kataoka et al. , 1995 . Therefore, the intersection of the AP-1 family proteins with the even larger number of potential CNC/small Maf interactions places these heteromeric transcription factors at the crux of a complicated, yet potentially exquisitely sensitive, regulatory network. One can envision how each of these proteins might contribute to a very sensitive ''on/off'' transcriptional switch, which could be finely titrated based simply on their relative activities inside cells at specific times during development (Engel 1994 ; Motohashi et al. 1997 ).
Gene targeting has revealed distinct roles for several CNC family members in mammalian gene regulation. nrf1-null mutants display a nonautonomous defect in mesoderm formation and fail to develop beyond embryonic day (E) 7.5 (Farmer et al. 1997) . nrf2-null mutants, on the other hand, are viable (Chan et al. 1996; Itoh et al. 1997 ) but impaired in the xenobiotic inductive response of phase II drug detoxifying enzyme genes (Itoh et al. 1997) . Most germane to the present study, p45 homozygous mutant mice display profound thrombocytopenia as a result of impaired megakaryocyte differentiation, leading to postnatal death (Shivdasani et al. 1995) .
Recently, the mouse mafK gene was disrupted by gene targeting. In contrast to p45 and nrf1-null mutants, however, the mafK mutant mice were viable, fertile, and apparently normal and healthy (Kotkow and Orkin 1996) . Because the small Maf proteins can functionally substitute for one another in vitro in the NF-E2 DNA-binding complex (Igarashi et al. 1994) , it was suggested that another small Maf protein might provide a complementing activity that rescues mafK homozygous mutant animals. This result was somewhat disquieting, however, as MafK is not ubiquitous, but is restricted within well defined cell lineages , as are the two other small Maf proteins (J. Akasaka, in prep.). Therefore, the observation that the mafK germ-line mutation led to no phenotype raised the spectre that the small Maf proteins might not be required for CNC family interactions in vivo, and that the genuine partner molecule(s) required for CNC activation was yet to be defined.
To address this question, we explored the functional roles of MafG and MafK in the mouse by replacing the entire coding regions of both the mafG and mafK genes with the lacZ gene. No defects were observed in mafK −/− mice, in accord with a previous report (Kotkow and Orkin 1996) . In contrast, although mafG −/− animals were also viable and fertile, they exhibited abnormal megakaryocyte proliferation with accompanying thrombocytopenia, as well as behavioral defects. Furthermore, the mafG and mafK genes display almost perfectly complementary expression patterns in early embryos, and the patterns of both genes become more complicated from E8.5 onward.
These results show that although the small Maf proteins can compensate for some embryonic functions when they are expressed in the same tissue, other roles of the small Maf factors are complementary and therefore cannot be fully compensated. This is most readily apparent during megakaryopoiesis and neurogenesis, where mafG −/− animals display physiological defects from the loss-of-function mutation, thereby demonstrating for the first time that the small Maf proteins are physiologically required in vivo.
Results

Targeting of the mafG and mafK genes
To elucidate possible roles for the small Maf proteins in murine development, we generated loss-of-function mutations in the mafG and mafK genes by deleting their entire coding sequences (J. Akasaka, in prep.; Motohashi et al. 1996) . Targeting vectors were designed to replace the coding exons with selectable markers; in the case of mafG, loxP sites surrounded the MC1neo/MC1HSVtk cassette (Fig. 1a) , whereas for mafK, loxP sites were placed around a phosphoglycerate kinase (PGK)-neo cassette (Fig. 1e) . Immediately 5Ј to these markers, and replacing the endogenous translation initiation sites present in each of the mafG or mafK second exons, the lacZ gene was inserted, thereby allowing the small maf genes to be individually monitored by X-gal staining. Diphtheria toxin and thymidine kinase were used as negative selection markers in the mafG and mafK targeting cassettes, respectively (Fig. 1a,e) .
R1 embryonic stem (ES) cells (Nagy et al. 1993) were electroporated with the linearized targeting constructs, and for mafG targeting 19 of 456 colonies were identified as homologous recombinants by PCR (Fig. 1b) ; eight of these positive clones were confirmed by Southern blotting (Fig. 1c) . In the case of mafK, five of 68 colonies were shown to be properly integrated by Southern blotting (Fig. 1f) . All of the ES clones were confirmed by additional restriction enzyme digests and Southern blotting (data not shown). The selected clones were then aggregated with eight-cell diploid embryos. Two mafG and three mafK clones produced chimeras that passed the mutant alleles to first generation offspring. The chimeras were bred to both CD1 and C57BL/6J mice for subsequent studies (Fig. 1d,g ). mafK and mafG homozygous null mutant animals are viable and fertile Heterozygous F 1 offspring were intercrossed and the resulting pups were examined and genotyped between birth and 2 weeks of age. The results of breeding experiments from the three mafK lines in the CD1 background showed that they displayed a normal Mendelian ratio of offspring (Table 1) . mafG homozygous mutant mice were born at a lower than expected ratio. This result was not statistically significant (P > 0.1) in the C57BL/6J background, but was in the CD1 background (P < 0.01; Table 1 ). RNase protection experiments on samples taken from multiple tissues showed that both targeting events resulted in null mutations in the respective genes (H. Motohashi, unpubl.) .
Impaired thrombopoiesis in mafG mutant mice
Because NF-E2 has been demonstrated to be a key regulatory molecule in thrombopoiesis (Shivdasani et al. 1995) , and all previous literature suggested that the required partner for p45 was a small Maf molecule, we first analyzed the peripheral blood of mafG and mafK homozygous mutant animals. The platelet count was dramatically diminished in mafG mutant mice, whereas all other blood cell lineages were unaffected by the mutation (Table 2 ; data not shown). Furthermore, histological analysis revealed a threefold increase in the number of megakaryocytes in both the bone marrow and in spleen sections of mafG −/− animals in comparison with heterozygous littermates ( Fig. 2a,b ; Table 2 ). In addition, mafG −/− megakaryocytes displayed both anti-glycoprotein IIb immunoreactivity and acetylcholinesterase activity (Jackson 1973; Beckstead et al. 1986 ; Fig. 2c,d ), indicating a late differentiation block in megakaryocyte maturation, as is also the case for p45 mutant mice. In contrast, mafK +/− and mafK −/− mice exhibited normal hematopoietic parameters (Table 2 ; data not shown), consistent with earlier results (Kotkow and Orkin 1996) . Therefore, MafG is required for terminal differentiation The mafG data are from one chimera crossed into either the C57BL/6J or CD1 genetic background. The mafK matings are for three different ES clones (in parentheses), all bred into the CD1 background. during thrombopoiesis, demonstrating for the first time a functional requirement for a small Maf protein.
Behavioral analysis reveals additional MafG functions in the nervous system
Further observations indicated that the mafG −/− pups might display deficits in addition to the one identified in hematopoiesis. These unexpected deficiencies appeared to be of neuronal origin, and were more obvious in the C57BL/6J than in the CD1 background, and therefore we report observations only in C57BL/6J mice.
The presumptive neurological defect was first noted when newly weaned mice were held inverted by the tail during cage changes, where homozygous mutant pups could be easily and uniformly identified by their response to handling. Instead of employing a typically smooth sideways motion to reach upward, as in their wild-type or heterozygous littermates, mafG −/− pups convulsively attempted to throw themselves into an upright position (data not shown). This behavior became less obvious as the mice aged (5-6 months), but was replaced by a new behavior, clasping their hindlegs together when inverted, another uncharacteristic response which is not observed in heterozygous littermates or wild type animals ( Fig. 3a) .
To quantify these behavioral abnormalities, we initially tested the animals in some simple behavioral tasks. mafG −/− adults were permitted to grab a thin wire with their forepaws, and were then left to hang, and their responses examined. Wild-type or heterozygous mutant animals immediately grabbed the wire with their hindpaws and were able to hold themselves or balance on top of the wire for an average of 51 sec. The majority of homozygous mafG mutants, on the other hand, were unable to grasp the wire with their hindlimbs-they hung briefly before dropping to the surface below (Table  3) . A second test, that would not so obviously require well developed musculature, was performed by placing the mice on a 10-ml glass pipette. The results were the same as for the wire hang task-nearly all mafG −/− animals were unable to support themselves for longer than 15 sec, whereas littermates could maintain this balanced position for 1 min (the test time limit; Table 3 ).
To characterize the mafG mutant animals more extensively, we subjected them to a battery of additional neurological tests (Crawley and Paylor 1997) and to open field testing. Heterozygous and homozygous mutants were indistinguishable in appearance (except in size, below) or gross neurological behavior in an empty cage; furthermore, in several additional tests (swimming, rearing, rolling, righting), mafG +/− and mafG −/− animals responded similarly. In the open field test, we found no statistically significant differences in time spent in the center or periphery of the field, number of squares traversed, number of rearings, freezing time, or number of fecal boli (n = 4 mafG
; data not shown). Therefore, the effect(s) of the mafG mutation on the nervous system, although very restricted, appears to be fully penetrant. −/− littermate shows expansion of the megakaryocyte population. In addition, these show a dosage dependent increase in staining, attributable to the presence of one additional expressed copy of lacZ. mafG −/− megakaryocytes from adult bone marrow are positive for anti-glycoprotein IIb antibody reactivity (c) and for acetylcholinesterase activity (d) (Jackson 1973; Beckstead et al. 1986 ). mafG defects in platelet formation and behavior
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The small maf homozygous mutant animals survived beyond weaning with no apparent difficulty. Some mafG −/− animals, however, were obviously smaller than their littermates (Fig. 3b) . This was quantified by weighing pups at different ages; mafG mutant pups showed a significant disparity from their littermates postnatally through adulthood. This was found in both the C57BL/6J (Fig. 3c,d ) and CD1 (not shown) backgrounds. In almost all litters examined, homozygous mutant females weighed less than their littermates (Fig. 3c ), but this phenotype was less penetrant for males (Fig. 3d) . We averaged the weights of the wild-type and heterozygous animals (these two classes did not show any significant disparities) from individual litters, and then calculated the normalized percentage of each individual relative to its litter average for all time points examined. These values showed that mafG −/− females and males had respective mean weights of 71.2% and 82.3% of the mafG +/+ and mafG +/− animals. Once again, mafK homozygous mutants exhibited no similar discrepancy (data not shown).
Complementary expression of the mafK and mafG genes during murine embryogenesis
To elucidate further the molecular mechanisms that might underlie the mafG gene null mutant-specific phenotypes, we characterized the mafG and mafK expression patterns using the inserted lacZ genes as reporters to detect ␤-galactosidase (␤-gal) activity. The rationale for this analysis was that if the mafG-specific phenotypes were attributable to a lack of compensation by other small Maf proteins, we might be able to identify nonoverlapping sites of expression of both the mafG and mafK genes through such an analysis. Matings were therefore conducted between heterozygous animals of a mixed 129/CD1 background, and the litters were examined at E6.5, E7.5, E8.5, E9.5, E10.5, E12.5, and E14.5. At stages after E9.5, embryos were genotyped by PCR.
Although differences were not observed either in embryonic development or in staining patterns between heterozygous versus homozygous mutant embryos, the homozygous mutants showed uniformly more intense staining (data not shown). In embryos that were not genotyped (before E9.5), three staining classes were observed-lesser staining (presumed to be heterozygous), more intensely staining (presumptive homozygous mutant), and no visible staining (classified as wild type).
At E6.5, to our surprise, mafG and mafK exhibited almost perfect mutually exclusive staining patterns (Fig.  4a,b) . A comparison of the mafG −/− and mafK −/− wholemount stained embryos displayed an obvious and striking contrast-mafG and mafK expression clearly demarcated the epiblast/extraembryonic boundary. mafG was clearly expressed in the embryonic ectoderm and mesoderm, with very weak staining in extraembryonic tissues. In contrast, mafK mutant embryos intensely stained the ectoplacental cone and extraembryonic endoderm. Although the two genes shared a spotted staining pattern across the entire embryo, which was not observed in wild-type embryos (data not shown), it was unclear from this analysis alone whether or not the two spotted patterns overlapped. At E7.5, the expression pat- mafG homozygous mutants and heterozygous littermates were subjected to the wire hang and balancing tasks, as described (Materials and Methods). terns for both genes were essentially unchanged, with mafG expressed throughout most of the embryo and mafK expressed primarily in developing extraembryonic endoderm (data not shown).
At E8.5, mafG expression was still strong throughout the entire embryo, with especially intense staining in the neural tube. At this stage, the mafG pattern began to intensify in the ectoplacental cone but only weakly stained the extraembryonic tissues (Fig. 4c) . This same pattern persisted into E9.5 (Fig. 4e) , when weak staining in the yolk sac blood islands first became detectable. At E8.5, mafK staining was also intense in the ectoplacental cone and in the yolk sac visceral endoderm (Fig. 4d) . By E9.0 the entire yolk sac endoderm displayed very intense mafK staining. Weak neural tube expression of mafK became apparent, and this continued into E9.5 along with the yolk sac and ectoplacental cone staining (Fig. 4f) . mafG continued to be expressed throughout almost the entire embryo at E9.5, E12.5, and E14.5 ( Fig. 4g ; data not shown). Some additional sites of particularly intense mafG expression were in the epithelium of the intestine, skeletal muscle, lens and retina, brain, and both cranial nerve and dorsal root ganglion cells ( Fig. 4i ; data not shown). In contrast to the quite broad embryonic expression of mafG, during this same period mafK was restricted to intense staining in the placenta, hematopoietic cells of the fetal liver (Fig. 4h) , yolk sac endoderm, epithelium of the intestine (Fig. 4j) , and the heart (data not shown).
After birth, both mafG and mafK were strongly expressed in the epidermis, hair follicles, epithelium of the digestive and respiratory tracts, and kidney tubules (data not shown). Many of these are proliferating tissues, implying that the small Maf proteins may have particularly important roles in cell growth or division. In adult mice, mafG and mafK displayed expression in both overlapping as well as individually distinct tissues. In some, such as tubules of the kidney, both mafG and mafK were strongly expressed, but in other tissues, one was far more predominant (see below).
Differential expression of mafG and mafK suggests mechanisms for mafG
−/− -specific phenotypes
As mafG mutant mice showed a specific thrombopoietic phenotype, we sought to investigate this defect further by analyzing ␤-gal activity in megakaryocytes synthesized in either mafG or mafK mutant animals. During embryonic development, at E12.5, we found that mafG (Fig. 5a ) and mafK (Fig 5b) were both expressed strongly in differentiating megakaryocytes of the fetal liver, as well as in newborn pups (data not shown). Adult mice (>2 months), however, showed differential expression. Whereas mafG was strongly expressed in adult mega- 
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We sought to understand the underlying mechanism responsible for the behavioral phenotype. Motor behavior is a product of first sensing body position, followed by the ability to respond and modulate this position. The former function is performed by the vestibular system (saccule and utricle) and the semi-circular canals of the inner ear, whereas the latter is carried out by the cerebellum. We postulated that either (or possibly both) of these tissues might represent sites of prominent mafG expression. If so, and if mafK were not expressed there, then a tissue defect at either site would become an excellent candidate as the basis of the observed neurological mafG −/− mutant phenotypes. Because the area of the inner ear is firmly embedded in bone in adults and decalcification would destroy any ␤-gal activity there, we examined the developing vestibular system in newborn animals. These experiments showed that vestibular ganglia and sensory cells of the saccule specifically expressed mafG, but not mafK ( Fig.  6a ; data not shown). In addition, mafG was expressed strongly in the cerebellum (Fig. 6b) , whereas mafK was not (Fig. 6c) . Therefore, it is possible that deficiencies in either or both of these neurological systems may underlie the observed behavioral deficits.
Discussion
We have carried out a genetic loss-of-function analysis for two of the three small Maf proteins, and also have analyzed the expression profiles of these two small maf genes using a ␤-gal reporter inserted into each locus. Whereas MafG and MafK display overlap in expression at several sites and during several periods where the two might provide compensatory activity, there are also many sites and times during development where expression of the two factors is not overlapping, and therefore they certainly cannot compensate for one anothers' activities there. We show here that, individually, MafG and MafK are both dispensable for mouse viability and fertility. In each homozygous null mutant animal, the remaining two small Maf proteins can presumably compensate for the loss of any one. These data also show, however, that there are at least two functions for MafG, in megakaryocyte differentiation and neural development, which are not fully compensated by residual MafK and/or MafF expression. These results therefore provide the first direct proof that the small Maf proteins are required for specific physiological functions during development.
One of the three major mafG −/− -specific phenotypes is thrombocytopenia. This phenotype is especially intriguing in that, in mice bearing a p45 gene disruption, ∼90% of the homozygous mutants die of severe hemorrhage, secondary to nearly complete thrombocytopenia caused by a late block in megakaryocyte maturation (Shivdasani et al. 1995) . Similarly, MafG-deficient mice are impaired in producing platelets, but do not show a propensity to hemorrhage. The most likely interpretation of these data is that MafG is the predominant partner molecule of p45 during megakaryopoiesis. Presumably a low level of residual MafK and/or MafF expression in megakaryocytes partially sustains thrombopoiesis, and therefore the phenotype of MafG deficiency is less severe than the loss of p45 (i.e., the mafG loss-of-function mutation is a hypomorphic phenocopy of the homozygous p45 mutation). In addition to the platelet deficiency, the number of megakaryocytes increases in the bone marrow and spleens of mafG mutant animals. This may be attributable to a combination of maturation arrest at the final stage of megakaryocytic differentiation caused by a lack of active NF-E2 (p45:MafG heterodimer) activity, as well as to a compensatory homeostatic increase in megakaryocyte proliferation induced in response to the decreased platelet number.
The second phenotype displayed by mafG −/− mice is age-dependent behavioral abnormalities. In two simple behavioral tasks, mafG homozygous mutant adults were quantifiably different than their wild-type and heterozygous littermates, confirming suspicions of a vestibular, neurological, or muscle defect, whereas the results of the balancing task imply that the defect is probably not muscular in origin. Furthermore, there are quite distinct differences in expression of the two proteins in the CNS, where MafG/lacZ is far more strongly expressed, implying that MafG is also much more abundant (in the forebrain, midbrain, cerebellum, retinal ganglion cell layer, and the sensory epithelium of the internal ear) than is MafK. We conclude that loss of MafG results in a neurological defect, probably within the cerebellum or the inner ear, although the detailed physiological abnormalities specifically responsible for the observed behavioral phenotypes are yet to be determined.
Tracing the ''knock-in'' reporter gene activity during embryogenesis defined a strikingly distinct pattern of expression of the mafG and mafK genes as early as E6.5. At this point in development, the expression of these two small Mafs essentially defines the junction between extraembryonic and embryonic tissues. On the other hand, especially after birth, the expression patterns of MafG and MafK expand and become complex, encompassing many different tissues and organs. In particular, we note that many sites of expression are proliferating tissues, such as epidermis, hair follicles, digestive and respiratory tract epithelia, and bone marrow, implying that the small Mafs may also have a role in cell growth or division.
The embryonic expression patterns and apparent lack of embryonic developmental phenotypes for mafG-and mafK-mutant mice beg the question: Do these small Mafs compensate for one another during development? There are two possible ways in which such compensation could occur. When one of the small Maf genes is mutated, the overlapping expression of another might contribute to the required activity. Alternatively, ablation of one gene could induce the expression of either one or both of the two remaining small maf genes in that tissue. These possibilities should be considered for several key times and sites of small maf expression, such as the yolk sac from E9.5-10.5, or in the fetal liver at E12.5, where both of these small Maf proteins are expressed at high levels. To determine if these represent important sites and/or times during development when the small maf genes must compensate for one another, it will be necessary to generate and examine compound mafG −/− :: mafK −/− mutant animals. If these genes are compensatory in the yolk sac or fetal liver, one should observe lethality in the compound mutants before, or during, this crucial period (E9.5-E12.5) when the embryo switches from primitive to definitive hematopoiesis (Copp 1995) . Strong expression of mafG and mafK is also detected in the ectoplacental cone beginning at E8.5 and continues in the placenta through E14.5, so the possibility also exists that uncompensated compound mutants might die during this time frame. In the latter scenario, the small Mafs could be critical for forming a normal placenta to ensure the transition from diffusion-based to placental nutrition (Copp 1995) . These intercross mating experiments, as well as detailed expression analysis of the small Mafs in the mutant mice, are ongoing.
Materials and methods
Construction and preparation of targeting vectors
The vector ploxPneo1 (the gift of A. Nagy, Mount Sinai Hospital, Toronto, Ontario, Canada) was used to construct the mafK targeting vector. It contains a mutant neomycin resistance gene derived from pPNT (Tybulewicz et al. 1991) flanked by loxP sites and driven by the mouse PGK promoter. To construct ploxPneo-HA-SS-␤-gal, the SmaI-NotI and NotI-SalI fragments (coding region and poly(A) signal of Escherichia coli ␤-gal, respectively) were excised from pSV␤ (Clontech) and cloned into the EcoRV and HindIII-SalI sites of pBluescript SK+ (pBS), respectively (p␤-gal). Next, a 1.8-kb SmaI-SmaI fragment containing 5Ј genomic sequence and exon IN was inserted into the pBS EcoRI site of p␤-gal. Finally, an XhoI-HindIII fragment that contains the herpes simplex thymidine kinase gene flanked by polyoma virus enhancers (PyTK; Mansour et al. 1988 ) was inserted into the SmaI site in the pBS polylinker. Ligation of blunted XhoI and SmaI sites regenerated the XhoI site, and a clone with this XhoI site opposite ␤-gal was selected, and designated pTK-SS-␤-gal.
A 6.6-kb HindIII-AscI genomic fragment of mafK containing the 3Ј end of the third exon and 3Ј flanking sequences was cloned into the SmaI site of ploxPneo1 (ploxPneo-HA). Next, the XhoI fragment from pTK-SS-␤-gal, consisting of PyTK, mafK sequences, and ␤-gal, was inserted into the XhoI site of ploxPneo-HA, thus completing ploxPneo-HA-SS-␤-gal (ploxPneo-␤-gal). This vector deleted the second and third (both coding) exons, and left ␤-gal under control of the mafK locus.
The mafG targeting vector was constructed using the plasmid pNATA (the generous gift of Y. Nabeshima, National Institute of Neuroscience, Tokyo, Japan). This plasmid contains the neomycin resistance and thymidine kinase (neo/TK) genes, each driven by individual MC1 promoters (Mansour et al. 1988 ) and flanked by loxP sites. The gene for diphtheria toxin subunit A (DT), also transcriptionally directed by the MC1 promoter, was added for negative selection. A 1.4-kb SacI-SmaI genomic fragment containing the 5Ј end of the second exon was inserted into the EcoRI site of p␤-gal, creating pScSm-␤-gal. An 8.0-kb EcoR-V-SalI genomic fragment downstream from the presumed third exon was inserted into the HpaI site of pNATA (pNATA-EVSI).
Finally, the NotI-SalI fragment from pScSm-␤-gal was cloned into the SalI site of pNATA-EVSI, creating the targeting Vector pNATA-DT-EVSI. This construct deleted the second and third exons, leaving lacZ under control of the mafG locus.
Gene targeting in ES cells
R1 ES cells (Nagy et al. 1993) were cultured on mitomycin Ctreated primary mouse embryonic fibroblast feeders (prepared according to Hogan et al. 1994 ) on gelatinized tissue culture plates essentially as described (Wurst and Joyner 1993) . The medium consisted of high glucose Dulbecco's Modified Eagle Medium (DMEM) and 15% fetal bovine serum (FBS, HyClone), supplemented with non-essential amino acids, glutamine, sodium pyruvate, ␤-mercaptoethanol, penicillin/streptomycin, and 1000 units/ml of leukemia inhibitory factor (ESGRO, GIBCO-BRL).
ploxPneo-␤-gal and pNATA-DT-EVSI were linearized with NotI, extracted with phenol:chloroform, precipitated, and resuspended in TE buffer. The R1 cells were trypsinized and resuspended in either PBS or ES medium, and from 5.6 to 10 × 10 6 cells were electroporated with 25 µg of linearized targeting vector at 240 V, 500 µF, and placed on ice for 20 min. Each cuvette was subsequently plated on a 100-mm plate of feeder cells derived from a mouse containing the gene for neomycin resistance (Genome Systems or The Jackson Laboratory). The cells were cultured for 24-48 hr before G418 (GIBCO-BRL) and Gancyclovir (Syntex) were added at concentrations of 210 µg/ml (active component) and 2 µM, respectively. Medium was changed daily, and selection was maintained for 8 days, by which time colonies were visible to the naked eye.
Individual colonies were picked under 10-40 × magnification, grown on feeders in 96-well plates, and replica-plated, using one plate for DNA and the other as a frozen stock, as described (Ramirez-Solis et al. 1992 ). In the case of mafK targeting, 68 colonies were screened by Southern blotting using a 5Ј external probe (a 0.6-kb XbaI fragment 2.0-kb 3Ј to exon IM), which identified 5 colonies with a 10.0-kb mutant BglII fragment in addition to the 6.9-kb endogenous fragment. For mafG, PCR screening was performed using a 5Ј primer just upstream of the short arm SacI site, and a 3Ј primer in the 5Ј region of the lacZ gene. Twenty-one clones were identified, yielding a targeting frequency of 1 in 22. Eight were confirmed by Southerns to be properly targeted clones by the presence of a polymorphic 6.4-kb BamHI fragment, in addition to the wild-type 5.3-kb fragment.
Generation of mutant mice
Chimeric mice were derived as described (Nagy and Rossant 1993) except that single eight-cell diploid embryos from CD1 egg donors (Charles River) were used for each aggregation. The aggregates were cultured overnight, and 8-12 blastocysts were transferred to each uterine horn of pseudopregnant CD1 females. Chimeras of greater than 50% ES cell contribution (estimated by coat color) were mated to CD1 females. Three mafK and two mafG targeted ES clones passed the mutation to F 1 offspring. Subsequently, the transmitting chimeras were mated to C57BL/6J mice to transfer the mutant allele to this background.
Genotyping of progeny was done by Southern blot and PCR analysis of tail DNA (Hogan et al. 1994) . Briefly, the tips of mouse pup tails were digested overnight in lysis buffer [100 mM NaCl, 1.0% SDS, 50 mM Tris (pH 8.0), 100 mM EDTA (pH 8.0), 0.35 mg/ml fresh proteinase K] at 55°C, phenol/chloroform extracted, and precipitated. For PCR analysis, a common primer 5Ј to exon 2 and two alternative 3Ј primers were designed to detect the three classes of progeny in a single PCR reaction. The 3Ј primer that detected the wild-type allele was in the second intron, whereas the 3Ј mutant allele primer corresponded to the 5Ј region of the lacZ gene.
Staining for lacZ gene (␤-gal) activity
The inserted lacZ gene was used to follow the small maf expression pattern by staining with X-gal (5-bromo-4-chloro-3-indolyl-␤-D-galactoside). 129/CD1 hybrid mice were used for these experiments. Noon on the day that a copulation plug was detected was considered day 0.5 of pregnancy. Pregnant females were sacrificed on the desired dates, and embryos were dissected and then immersed in fixative (1% formaldehyde, 0.2% glutaraldehyde, 0.02% NP-40 in PBS) at 4°C for 2 hr. After washing with PBS, the embryos were soaked in 20% sucrose overnight, and then embedded in OCT compound (Tissue-Tek, Sakura) and sectioned in a cryostat at −20°C. Subsequently, the embryos were stained with X-gal solution [0.1 M sodium phosphate at pH 7.3, 2 mM MgCl 2 , 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 0.01% sodium deoxycholate, 0.02% NP-40, 20 mM Tris-HCl, 1 mg/ml of X-gal] at 37°C overnight, and counterstained with nuclear fast red. Alternatively, embryos younger than E9.5 were usually stained at 30°C after fixation, and then processed as described above.
Assaying for glycoprotein IIb immunoreactivity and acetylcholinesterase activity
Femurs from 2-to 4-month-old mafG −/− animals were dissected and opened before fixation in 4% paraformaldehyde for 2 hr at 4°C, followed by overnight immersion in 20% sucrose. Bone marrow was then removed and embedded in OCT compound (Tissue-Tek, Sakura) and sectioned in a cryostat at −20°C. We incubated a new rat anti-mouse glycoprotein IIb monoclonal antibody (M. Yamamoto, unpubl.) with the sectioned bone marrow, followed by incubation with horseradish peroxidase-conjugated anti-rat IgG. Diaminobenzidine was used as chromogen, labeling positive cells with a brown color, followed by counterstaining with methyl green.
Acetylcholinesterase activity was determined essentially as described (Jackson 1973) . Briefly, the sectioned bone marrow was incubated for 1 hr at 37°C in a freshly prepared buffer containing 10 mg of acetylthiocholine iodide (Sigma) dissolved in 15 ml of 0.1M sodium phosphate (pH 6.0), with 1 ml of 0.1 M sodium citrate, 2 ml of 30 mM cupric sulfate, and 2 ml of 5 mM potassium ferricyanide. Positive cells became orange, and hematoxylin was used for counterstaining.
Hematological analysis
Four-month-old mice were euthanized with carbon dioxide and 0.5 ml of blood was drawn from the inferior vena cava into a syringe containing 5-10 µl of 0.5 M EDTA. The blood samples were analyzed by Anilytics, Inc. (Gaithersburg, MD).
The megakaryocyte percentage was determined by counting cells in the bone marrow. Femurs or tibias from mafG +/− and mafG −/− animals were dissected and flushed with PBS. Bone marrow cells were disaggregated by repeated flushing through a 21 gauge needle. Non-nucleated cells were removed by osmotic lysis with a hypotonic NH 4 Cl solution. The remaining cell suspension was counted in a 200 µm depth hemocytometer to allow free flow of megakaryocytes. The megakaryocyte percentage was calculated as follows: megakaryocyte % = megakaryocyte count nucleated cell count × 100 GENES & DEVELOPMENT Cold Spring Harbor Laboratory Press on November 2, 2017 -Published by genesdev.cshlp.org Downloaded from Behavioral analysis F 2 (129/B6) mafG +/− and mafG −/− mice were intercrossed to generate F 3 pups for behavioral testing. Animals were tested at 3-6 months of age. For the wire hang test, a wire ∼2 mm in diameter was employed. Mice were allowed to grab the wire with their forepaws, and then released so their hindlimbs dangled below. Timing was initiated after the mice were released, for a maximum of 1 min. For the balancing task, the mice were placed on a 10-ml pipette with their A/P axis parallel to the pipette. Again, timing began after the mice were released, with a 1 min limit.
Weights
Mice were weighed on a balance that measured to the nearest 0.1 gram. Mice younger than 5 days old (P5) were weighed to the nearest 0.1 gram. Mice older than 5 days were weighed to the nearest 0.5 gram because of their increased activity. The entire litter was examined at every time point for reference. To control for variation between different litters, a normalized percentage (norm%) was calculated as follows, where ''normal litter mean'' is the average weight of +/+ and +/− animals from a particular litter at a particular time point. norm % = individual weight normal litter mean × 100
